Analysis Viridian Therapeutics, Inc. (VRDN)
5/29/2024
Analysis of Viridian Therapeutics, Inc. (VRDN)
Viridian Therapeutics, Inc. (VRDN) has been experiencing some fluctuations in its stock price recently. The Relative Strength Index (RSI) values have been hovering around the mid-30s to mid-40s, indicating a neutral to slightly bearish sentiment among traders.The Moving Average Convergence Divergence (MACD) indicator has been showing negative values, suggesting a bearish trend in the stock price. However, the MACD histogram has been fluctuating around the zero line, indicating some indecision in the market.
The Moving Average (MA) indicator has been above the stock's current price, which could act as a resistance level. The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have been trending downwards, reflecting the recent decline in the stock price.
Overall, based on the technical indicators, Viridian Therapeutics, Inc. may be facing some selling pressure in the near term. Traders and investors should closely monitor the support and resistance levels to make informed decisions.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating that the company is facing higher production or acquisition costs.
3. The gross profit margin has remained relatively stable, with gross profit increasing along with sales revenue.
4. Operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has also been increasing over the years, from $57.4 billion in 2020 to $97 billion in 2023, indicating improved profitability.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally increased, with diluted EPS reaching $6.13 in 2023 from $3.28 in 2020.
7. The company has been able to maintain a healthy EBITDA margin, indicating efficient operational performance.
8. Overall, the financial performance of the company in terms of revenues has been positive, showing growth and improved profitability over the years.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with a significant portion in cash equivalents and short-term investments.
3. Non-current assets consist mainly of investments and advances, along with machinery, furniture, and equipment.
4. Total liabilities have also been increasing, but at a slower pace compared to assets.
5. Shareholders' equity has shown a positive trend, indicating a healthy financial position.
6. The company has been investing in leases, land, and improvements, reflecting a focus on long-term growth.
7. Accumulated depreciation is significant, suggesting the company has been using its assets efficiently.
8. The company has been managing its debt levels effectively, with a mix of short-term and long-term debt.
9. Overall, the financial health of the company seems stable and growing steadily over the years.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for the quarter ending on October 31, 2024, were not provided on time. However, on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits for a specific company.In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.44.
Moving on to stock statistics, the company has a short ratio of 1.66, with 94.31 million shares shorted out of 15.31 billion float shares. The average 10-day volume is 52.90 million shares, while the average 90-day volume is 62.82 million shares. The stock has a market capitalization of $2.91 trillion.
Valuation metrics show a PEG ratio of 26.21, forward P/E of 26.21, and trailing P/E of 29.43. The enterprise value is $2.95 trillion, with a price-to-book ratio of 39.18 and price-to-sales ratio of 7.62. The stock has an enterprise-to-EBITDA ratio of 22.75 and an enterprise-to-revenue ratio of 7.73.
The stock price summary includes a beta of 1.26, a 50-day moving average of $173.69, and a 200-day moving average of $180.79. The stock's 52-week low is $164.08, the high is $199.62, and the change over the past 52 weeks is 8.25%.
Lastly, in terms of dividends and splits, the company has a payout ratio of 14.93% and a forward annual dividend rate of $1. The stock's ex-dividend date is May 10, 2024, with a dividend date of May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split. The 5-year average dividend yield is 0.73% and the trailing annual dividend yield is 0.51%.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, compared to $1.26 a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, compared to $1.46 a year ago.
3. For the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, compared to $6.13 a year ago.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, compared to $6.59 a year ago.
Overall, analysts are projecting an increase in earnings per share for both the upcoming quarters and the next fiscal years, indicating positive growth expectations for the company.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year.
Overall, the analysts are forecasting moderate growth in both quarterly and annual sales for the company, indicating a positive outlook for the future performance of the business.
Growth estimates
Based on the consensus estimates provided:- The current year growth rate is 7.5%
- The next quarter growth rate is 4.8%
- The current quarter growth rate is 5.6%
- The next year growth rate is 9.7%
- The average annual growth rate for the next 5 years is 11%
- The average annual growth rate for the past 5 years is 20.15%
It is evident that the company is expected to experience a significant increase in growth rate compared to the past 5 years, with a particularly strong growth forecasted for the next 5 years. The growth rates are expected to vary over different periods, with the highest growth rate projected for the next 5 years.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the average and median both indicating a price higher than the current price. The low end of the forecast suggests a potential decrease in price, while the high end indicates a significant increase.
MACD of VRDN
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
